Centro Hospitalar Vila Nova de Gaia/Espinho, E.P.E.

Vila Nova de Gaia 4434-502

1 studies enrolling now · 8 studies all time

What they study most

Breast Cancer, Cardiovascular Diseases, Clostridium Difficile Infection, Colitis, Ulcerative, Diabetes Mellitus, Type 2, FSGS, First Line Non-Small Cell Lung Cancer, Hypertension, Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis

Studies at this site

• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
• A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast — Recruiting now
• A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB — Recruiting now
• Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis — Stopped early
• Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04] — Running, not enrolling
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• Clostridium Difficile Vaccine Efficacy Trial — Completed
• An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis — Completed